Correction to Shire's Generic Adderall XR Approval Story On June 25
10 July 2012 - 6:08PM
Dow Jones News
"Shire Sinks On Generic Adderall XR Approval But Rebound Seen"
at 1250 GMT on June 25 incorrectly said Watson Pharmaceuticals had
already bought Actavis in the second paragraph.
Watson is still in the process of buying Actavis.
Watson (NYSE:WPI)
Historical Stock Chart
From Apr 2024 to May 2024
Watson (NYSE:WPI)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Actavis, Inc. (New York Stock Exchange): 0 recent articles
More Watson Pharmaceuticals Inc. News Articles